Monika Gonka

Monika Gonka

Auto-generated profile, based on publicly available information

Monika Gonka

Department of Biology, York Biomedical Research Institute, University of York, York, United Kingdom

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2021 in The FEBS Journal
Verified
Journal Article
Open access
PDF file
ISIzabella Skulimowska
Izabella Skulimowska
JSJustyna Sośniak
Justyna Sośniak
MGMonika Gonka
Monika Gonka
ASAgata Szade
Agata Szade
AJAlicja Józkowicz
Alicja Józkowicz
KSKrzysztof Szade
Krzysztof Szade
Hematopoietic stem cells (HSCs) give rise to all types of blood cells and self‐renew their own population. The regeneration potential of HSCs has already been successfully translated into clinical applications. However, recent studies on the biology of HSCs may further extend their clinical use in future. The roles of HSCs in native hematopoiesis and in transplantation settings may differ. Furthermore, the heterogenic pool of HSCs dynamically changes during aging. These changes also involve the complex interactions of HSCs with the bone marrow niche. Here, we review the opportunities and challenges of these findings to improve the clinical use of HSCs. We describe new methods of HSCs mobilization and conditioning for the transplantation of HSCs. Finally, we highlight the research findings that may lead to overcoming the current limitations of HSC transplantation and broaden the patient group that can benefit from the clinical potential of HSCs.

10 August 2023 in Blood
Verified
Journal Article
Open access
PDF file
MJMaria Jassinskaja
Maria Jassinskaja
MGMonika Gonka
Monika Gonka
DKDavid G. Kent
David G. Kent
One of the most challenging aspects of stem cell research is the reliance on retrospective assays for ascribing function. This is especially problematic for hematopoietic stem cell (HSC) research in which the current functional assay that formally establishes its HSC identity involves long-term serial transplantation assays that necessitate the destruction of the initial cell state many months before knowing that it was, in fact, an HSC. In combination with the explosion of equally destructive single-cell molecular assays, the paradox facing researchers is how to determine the molecular state of a functional HSC when you cannot concomitantly assess its functional and molecular properties. In this review, we will give a historical overview of the functional and molecular assays in the field, identify new tools that combine molecular and functional readouts in populations of HSCs, and imagine the next generation of computational and molecular profiling tools that may help us better link cell function with molecular state.